Harlan Waksal Insider Trading $ELOX Eloxx Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Harlan Waksal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Harlan Waksal. Harlan Waksal is Director in Sevion Therapeutics, Inc. ($SVON) and President, CEO in Kadmon Holdings, Inc. ($KDMN).
Harlan Waksal in Eloxx Pharmaceuticals, Inc.
Trading Symbol: ELOXIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Harlan Waksal: Director
Holdings: 822,168 shares
Current Value: $189,099
Latest Transaction: Nov 23 2015
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Harlan Waksal in Eloxx Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 23 2015 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.50 | 40,000 | 20,000 | 40,000 | |
May 20 2015 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.97 | 11,340 | 11,000 | 147,693 | |
Feb 23 2015 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.54 | 26,552 | 14,338 | 136,353 | |
May 19 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.27 | 51,852 | 14,000 | 1,157,654 | |
Feb 16 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.29 | 45,690 | 13,250 | 1,105,802 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 500,000 | 130,000 | 1,060,112 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 200,000 | 52,000 | 560,112 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 96,154 | 25,000 | 360,112 | |
Jun 03 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.32 | 200 | 64 | 200 | |
Jun 03 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.35 | 625,000 | 218,750 | 1,167,333 | |
May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | C | 0.83 | 631,176 | 523,876 | 822,168 | 191 K to 822.2 K (+330.47 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Grant | A | 0.51 | 12,078 | 6,202 | 190,992 | 178.9 K to 191 K (+6.75 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Grant | A | 0.37 | 28,135 | 10,334 | 178,914 | 150.8 K to 178.9 K (+18.66 %) |
May 24 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.61 | 22,951 | 14,000 | 263,958 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.83 | 87,313 | 72,470 | 542,333 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.83 | 130,969 | 108,704 | 455,020 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 87,313 | 88,186 | 324,051 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 130,969 | 132,279 | 236,738 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 1.01 | 78,581 | 79,367 | 105,769 | |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 135,779 | 0 | 150,779 | 15 K to 150.8 K (+905.19 %) |
Feb 23 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.29 | 77,500 | 22,475 | 241,007 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.39 | 70,000 | 27,300 | 163,507 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.39 | 66,923 | 26,100 | 93,507 | |
Nov 23 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.59 | 19,492 | 11,500 | 26,584 | |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 13,688 | 0 | 27,188 | 13.5 K to 27.2 K (+101.39 %) |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.00 | 13,500 | 0 | 13,500 | 0 to 13.5 K |
Jul 31 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.90 | 15,000 | 13,500 | 15,000 | 0 to 15 K |
Feb 24 2009 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.47 | 7,092 | 3,333 | 7,092 |
Page: 1